Search Within

GDMT, Medicine

Formats
  1. Journal Article (935)
  2. Meeting Abstract (836)
  3. Review (49)
  4. Book Section (38)
  5. Editorial (30)
  6. Guidelines (19)
  7. Correspondence (7)
  8. Research Letter (1)
Groups
  1. Gynecology Disease Management Team (1915)
  2. Department of Medicine (1904)
  3. Solid Tumor Oncology Division (1904)
  4. Gynecologic Medicine Service (1864)
  5. Surgery (585)
  6. GDMT, Surgery (467)

More Groups

People
  1. Carol Aghajanian (616)
  2. Martee Hensley (290)
  3. Nadeem Abu-Rustum (281)
  4. Roisin O'Cearbhaill (275)
  5. Vicky Makker (270)
  6. Paul Sabbatini (262)

More People

Years
  1. 2025 (78)
  2. 2024 (159)
  3. 2023 (165)
  4. 2022 (196)
  5. 2021 (146)
  6. 2020 (173)

More Years

Publications
  1. Journal of Clinical Oncology (421)
  2. Gynecologic Oncology (419)
  3. International Journal of Gynecological Cancer (156)
  4. Annals of Oncology (107)
  5. Clinical Cancer Research (65)
  6. Cancer (37)

More Publications

Publishers
  1. American Society of Clinical Oncology (453)
  2. Elsevier B.V. (443)
  3. Lippincott Williams & Wilkins (181)
  4. American Association for Cancer Research (141)
  5. Oxford University Press (130)
  6. Elsevier Inc. (83)

More Publishers

Results (1915)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • First-in-human trial of intravenous MEDI9253, an oncolytic virus, in combination with durvalumab in patients with advanced solid tumors
    Meeting Abstract

    Purroy, N.; Durham, N.; Phillips, M.; Hattersley, M. M.; Jung, L.; Davar, D.; Zamarin, D.; Johanns, T. M.; Puzanov, I.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Optimization of shared neoantigen vaccine design to increase vaccine potency: From bench to bedside and back
    Meeting Abstract

    Rappaport, A. R.; Palmer, C. D.; Shen, A.; Dominguez, C. X.; Hart, M. G.; Kraemer, L. D.; Koulavouth, S.; Marrali, M.; Jaroslavsky, J. R.; Nganje, C. N.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • T cell intrinsic DNA damage and repair response as a novel marker associated with clinical response to PD-1 blockade
    Meeting Abstract

    Muroyama, Y.; Manne, S.; Oldridge, D. A.; Wellhausen, N.; Greenplate, A. R.; Chilukuri, L.; Mathew, D.; Xu, C.; Herati, R. S.; Huang, A. C.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Synthetic lethality by targeting ribonucleotide reductase in PP2A deficient uterine serous carcinoma
    Meeting Abstract

    O'Connor, C. M.; Taylor, S. E.; Miller, K. M.; Hurst, L.; Haanen, T. J.; Suhan, T. K.; Zawacki, K. P.; Noto, F. K.; Trako, J.; Mohan, A.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Lower doses of self-amplifying mRNA drive superior neoantigen-specific CD8 T cell responses in cancer patients versus high doses
    Meeting Abstract

    Palmer, C. D.; Rappaport, A. R.; Hart, M. G.; Kraemer, L. D.; Kounlavouth, S.; Marrali, M.; Jaroslaysky, J. R.; Nganje, C. N.; Shen, A.; Boucher, G. R.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Defining the balance of anti-viral and anti-tumor T cell responses to oncolytic virus therapy using single cell approaches
    Meeting Abstract

    Burman, B.; Ceglia, N.; Hirschhorn, D.; Budhu, S.; Mangarin, L.; Oseledchyk, A.; Bykov, Y.; McPherson, A.; Shah, S.; Wolchok, J.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Ancestry inference and population-specific disparities in a real-world clinical sequencing cohort
    Meeting Abstract

    Arora, K.; Tran, T. N.; Kemel, Y. M.; Mehine, M.; Liu, Y.; Smith, S. A.; Nandakumar, S.; Ostrovnaya, I.; Reynolds, T. C.; Offit, K.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Immune and malignant cell phenotypes of ovarian cancer are determined by distinct mutational processes
    Meeting Abstract

    Vázquez-García, I.; Uhlitz, F.; Ceglia, N.; Lim, J. L.; Wu, M.; Mohibullah, N.; Ruiz, A. E. B.; Boehm, K. M.; Bojilova, V.; Fong, C. J.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Creating a multidisciplinary protocol for the administration of hyperthermic intraperitoneal chemotherapy with cisplatin: A single-institution experience
    Meeting Abstract

    Praiss, A.; Moukarzel, L.; Dessources, K.; Sonoda, Y.; Roche, K. L.; Gardner, G.; Tew, W.; Grisham, R.; Chi, D.; O'Cearbhaill, R.; more...
    International Journal of Gynecological Cancer (2022)

    Fulltext@MSK | Save
  • Keynote-C93/GOG-3064/ENGOT-EN15: Phase 3, randomized, open-label study of first-line pembrolizumab versus platinum-doublet chemotherapy in mismatch repair deficient advanced or recurrent endometrial carcinoma
    Meeting Abstract

    Slomovitz, B.; Cibula, D.; Gultekin, M.; Mirza, M.; Maćkowiak-Matejczyk, B.; Taylor, A.; Romero, I.; Colombo, N.; Korach, J.; Zhu, J.; more...
    International Journal of Gynecological Cancer (2022)

    Fulltext@MSK | Save